PKM and cancer: Meanwhile, studies have proved that TEPP-46, as an activator of PKM2 pyruvate activity, mimics the PKM1 properties in PKM2-expressing cells, therefore inhibits cancer cell proliferation in vitro and xenograft tumor growth in vivo [53, 55].